Integration between the Tandem Diabetes Care t:slim X2 insulin pump and the Dexcom G7 continuous glucose monitoring (CGM) sensor is currently in development.
Tandem has previously communicated that our goal is to launch our integrated offerings within one to two quarters (3-6 months) of Dexcom G7 receiving FDA clearance. We will provide updates on t:slim X2 pump and sensor integration.
Tandem pumps have successfully integrated with Dexcom G4, G5, and G6 CGMs through the years. Tandem is committed to delivering an integrated solution as quickly as possible.
ZD-000197_B
